ES2032831T5
(es)
*
|
1986-08-19 |
2001-02-16 |
Genentech Inc |
Dispositivo y dispersion para suministro intrapulmonar de factores de crecimiento polipeptidos y citoquinas.
|
US5037644A
(en)
*
|
1986-10-27 |
1991-08-06 |
Cetus Corporation |
Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
|
US4944941A
(en)
*
|
1987-08-07 |
1990-07-31 |
Genentech, Inc. |
Methods and compositions for the treatment of lung conditions
|
JP2739733B2
(ja)
*
|
1988-08-09 |
1998-04-15 |
オムロン株式会社 |
吸入器
|
US5198212A
(en)
*
|
1988-10-31 |
1993-03-30 |
University Of Lousville Research Foundation Incorporated |
Method and compositions for treatment of trauma-associated sepsis with gamma interferon
|
EP0377174A3
(de)
*
|
1988-12-22 |
1990-11-22 |
Büsselmann, Manfred |
Verfahren und Vorrichtung zum Zerstäuben und Vernebeln von flüssigen Stoffen
|
US4994439A
(en)
*
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
US5011678A
(en)
*
|
1989-02-01 |
1991-04-30 |
California Biotechnology Inc. |
Composition and method for administration of pharmaceutically active substances
|
JPH05963A
(ja)
*
|
1990-04-13 |
1993-01-08 |
Toray Ind Inc |
ポリペプチド類組成物
|
US5780012A
(en)
*
|
1990-06-21 |
1998-07-14 |
Huland; Edith |
Method for reducing lung afflictions by inhalation of cytokine solutions
|
ES2065434T3
(es)
*
|
1990-06-21 |
1995-02-16 |
Edith Dr Huland |
Utilizacion de aerosoles que contienen citocinas y aerosoles que contienen citocinas propiamente dichos.
|
US6565841B1
(en)
|
1991-03-15 |
2003-05-20 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
DE4117078A1
(de)
*
|
1991-05-25 |
1992-11-26 |
Boehringer Ingelheim Kg |
Verfahren zur herstellung therapeutisch anwendbarer aerosole
|
US6673335B1
(en)
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US5354934A
(en)
†
|
1993-02-04 |
1994-10-11 |
Amgen Inc. |
Pulmonary administration of erythropoietin
|
IL109350A
(en)
*
|
1993-05-12 |
2001-01-28 |
Genentech Inc |
Stable liquid preparations of gamma interferon
|
US5497763A
(en)
*
|
1993-05-21 |
1996-03-12 |
Aradigm Corporation |
Disposable package for intrapulmonary delivery of aerosolized formulations
|
US5512269A
(en)
*
|
1993-06-09 |
1996-04-30 |
Burroughs Wellcome, Co. |
Method of treating retained pulmonary secretions
|
AU689217B2
(en)
|
1994-03-07 |
1998-03-26 |
Novartis Ag |
Methods and compositions for pulmonary delivery of insulin
|
US20030113273A1
(en)
*
|
1996-06-17 |
2003-06-19 |
Patton John S. |
Methods and compositions for pulmonary delivery of insulin
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US5522385A
(en)
*
|
1994-09-27 |
1996-06-04 |
Aradigm Corporation |
Dynamic particle size control for aerosolized drug delivery
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5972331A
(en)
*
|
1995-12-22 |
1999-10-26 |
Schering Corporation |
Crystalline interferon alpha for pulmonary delivery and method for producing the same
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
ATE405651T1
(de)
|
1998-03-17 |
2008-09-15 |
Genentech Inc |
Zu vegf und bmp1 homologe polypeptide
|
SE9803770D0
(sv)
*
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Dry powder pharmaceutical formulation
|
DE19851380A1
(de)
*
|
1998-11-07 |
2000-05-11 |
Messer Griesheim Gmbh |
Parfümierung von Sauerstoff
|
AU6338200A
(en)
|
1999-06-28 |
2001-01-31 |
Genentech Inc. |
Methods for making apo-2 ligand using divalent metal ions
|
DK1808438T3
(da)
*
|
1999-06-29 |
2014-10-27 |
Mannkind Corp |
Rensning og stabilisering af peptid og proteiner i lægemidler
|
US9006175B2
(en)
*
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
JP3852256B2
(ja)
|
1999-11-10 |
2006-11-29 |
富士ゼロックス株式会社 |
インクジェット記録装置
|
JP2001187459A
(ja)
|
1999-12-28 |
2001-07-10 |
Fuji Xerox Co Ltd |
インクジェット記録装置
|
CA2395803A1
(en)
*
|
1999-12-30 |
2001-07-12 |
Intermune, Inc. |
Y-ifn liquid-droplet aerosol and method
|
EP1246609B1
(de)
*
|
2000-01-14 |
2010-03-31 |
Brown University Research Foundation |
Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln
|
US6585957B1
(en)
|
2000-01-25 |
2003-07-01 |
Aeropharm Technology Incorporated |
Medicinal aerosol formulation
|
JP2003524646A
(ja)
*
|
2000-01-25 |
2003-08-19 |
エアロファーム テクノロジー インコーポレイテッド |
医薬エアゾール製剤
|
WO2001085136A2
(en)
|
2000-05-10 |
2001-11-15 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
CA2648048A1
(en)
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
EP2792747A1
(de)
|
2000-06-23 |
2014-10-22 |
Genentech, Inc. |
Zusammensetzungen und Verfahren zur Diagnose und Behandlung von Erkrankungen in Verbindung mit Angiogenese
|
KR20030038690A
(ko)
|
2000-08-07 |
2003-05-16 |
인헤일 테라퓨틱 시스템즈 인크. |
응집이 최소화된, 흡입성 분무 건조 4-나선 다발 단백질분말
|
JP4931282B2
(ja)
*
|
2000-10-02 |
2012-05-16 |
日本ケミカルリサーチ株式会社 |
生理活性ペプチド含有粉末
|
US6689047B2
(en)
*
|
2000-11-15 |
2004-02-10 |
Scimed Life Systems, Inc. |
Treating urinary incontinence
|
AU2002230993B2
(en)
|
2000-12-29 |
2006-02-02 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
WO2003029462A1
(en)
*
|
2001-09-27 |
2003-04-10 |
Pieris Proteolab Ag |
Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
|
US7118915B2
(en)
*
|
2001-09-27 |
2006-10-10 |
Pieris Proteolab Ag |
Muteins of apolipoprotein D
|
EP2348043A1
(de)
|
2001-10-02 |
2011-07-27 |
Genentech, Inc. |
APO-2-Ligandvarianten und Verwendungen dafür
|
US7741282B2
(en)
|
2001-11-13 |
2010-06-22 |
Genentech, Inc. |
ApO2 ligand/TRAIL formulations
|
ATE508735T1
(de)
|
2001-12-19 |
2011-05-15 |
Novartis Ag |
Pulmonale verabreichung von aminoglykosiden
|
JP3636197B2
(ja)
|
2001-12-27 |
2005-04-06 |
日本精工株式会社 |
車両用チルト式ステアリング装置
|
US20040063912A1
(en)
*
|
2002-03-15 |
2004-04-01 |
The Brigham And Women's Hospital, Inc. |
Central airway administration for systemic delivery of therapeutics
|
US7008644B2
(en)
*
|
2002-03-20 |
2006-03-07 |
Advanced Inhalation Research, Inc. |
Method and apparatus for producing dry particles
|
US20050163725A1
(en)
*
|
2002-03-20 |
2005-07-28 |
Blizzard Charles D. |
Method for administration of growth hormone via pulmonary delivery
|
CA2478327A1
(en)
*
|
2002-03-20 |
2003-10-02 |
Advanced Inhalation Research, Inc. |
Hgh (human growth hormone) formulations for pulmonary administration
|
ES2425392T3
(es)
|
2002-03-20 |
2013-10-15 |
Mannkind Corporation |
Cartucho para un aparato de inhalación
|
EP2305710A3
(de)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetische Antikörperphagenbibliotheken
|
AU2003247609A1
(en)
|
2002-06-24 |
2004-01-06 |
Genentech, Inc. |
Apo-2 ligand/trail variants and uses thereof
|
AU2003255851B2
(en)
*
|
2002-07-08 |
2009-07-23 |
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. |
New compounds, compositions and methods for treatment of inflammatory diseases and conditions
|
WO2004005313A2
(en)
*
|
2002-07-08 |
2004-01-15 |
Pliva - Istrazivacki Institut D.O.O. |
Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
|
NZ563328A
(en)
|
2002-10-16 |
2009-08-28 |
Euro Celtique Sa |
Antibodies that bind cell-associated CA 125/0772P and methods of use thereof
|
HRP20030324A2
(en)
|
2003-04-24 |
2005-02-28 |
Pliva-Istra�iva�ki institut d.o.o. |
Compounds of antiinflammatory effect
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
JP2007517892A
(ja)
*
|
2004-01-12 |
2007-07-05 |
マンカインド コーポレイション |
2型糖尿病における血清プロインスリンレベルを低下させる方法
|
ATE433746T1
(de)
*
|
2004-03-12 |
2009-07-15 |
Biodel Inc |
Insulinzusammensetzungen mit verbesserter wirkstoffabsorption
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
CN101010305B
(zh)
|
2004-08-20 |
2010-08-11 |
曼金德公司 |
二酮哌嗪合成的催化反应
|
KR101644250B1
(ko)
|
2004-08-23 |
2016-07-29 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
MX2007005073A
(es)
|
2004-10-27 |
2007-06-25 |
Glaxosmithkline Zagreb |
Conjugados con actividad antiinflamtoria.
|
WO2006055950A1
(en)
*
|
2004-11-18 |
2006-05-26 |
Nektar Therapeutics |
Pharmaceutical dry powder formulation on the basis particles comprising multiple active agents
|
AR066386A1
(es)
*
|
2004-12-17 |
2009-08-19 |
Glenmark Pharmaceuticals Sa |
Compuestos heterociclicos condensados, metodos e intermediarios para su preparacion, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por la inhibicion de la pde-4
|
ES2417491T3
(es)
*
|
2004-12-17 |
2013-08-08 |
Glenmark Pharmaceuticals S.A. |
Novedosos compuestos heterocíclicos útiles para el tratamiento de trastornos inflamatorios y alérgicos
|
AU2006290227B2
(en)
|
2005-09-14 |
2012-08-02 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
WO2007041481A1
(en)
*
|
2005-09-29 |
2007-04-12 |
Biodel, Inc. |
Rapid acting and prolonged acting insulin preparations
|
DK1986679T3
(da)
|
2006-02-22 |
2017-11-20 |
Mannkind Corp |
Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof
|
JP2009533471A
(ja)
*
|
2006-04-12 |
2009-09-17 |
バイオデル, インコーポレイテッド |
即効型および長時間作用型組合せインスリン製剤
|
GB0617417D0
(en)
*
|
2006-09-05 |
2006-10-18 |
Concept 2 Manufacture Design L |
A nebuliser valve
|
WO2008124522A2
(en)
*
|
2007-04-04 |
2008-10-16 |
Biodel, Inc. |
Amylin formulations
|
JP5352596B2
(ja)
*
|
2008-01-04 |
2013-11-27 |
バイオデル, インコーポレイテッド |
組織グルコースレベルの関数としてのインスリン放出のためのインスリン製剤
|
JP4654266B2
(ja)
*
|
2008-05-14 |
2011-03-16 |
株式会社群馬コイケ |
ネブライザー
|
CA2728230C
(en)
|
2008-06-13 |
2017-10-17 |
Mannkind Corporation |
A dry powder inhaler and system for drug delivery
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
AU2009259883B2
(en)
|
2008-06-20 |
2015-02-05 |
Mannkind Corporation |
An interactive apparatus and method for real-time profiling of inhalation efforts
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
MX2011002418A
(es)
|
2008-09-10 |
2011-04-05 |
Genentech Inc |
Metodos para inhibir la angiogenesis ocular.
|
US20100105620A1
(en)
|
2008-10-10 |
2010-04-29 |
Anaphore, Inc. |
Polypeptides that bind Trail-R1 and Trail-R2
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
US8538707B2
(en)
|
2009-03-11 |
2013-09-17 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
EP2260857A1
(de)
|
2009-06-11 |
2010-12-15 |
Alfact Innovation |
Neuartige Anwendungen von HIP/PAP und Derivate davon
|
SG176738A1
(en)
|
2009-06-12 |
2012-01-30 |
Mannkind Corp |
Diketopiperazine microparticles with defined specific surface areas
|
EP2496295A1
(de)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
Vorrichtung und verfahren zur simulation von einatmungsanstrengungen
|
EP3660510A3
(de)
|
2009-12-07 |
2020-07-08 |
Pieris Pharmaceuticals GmbH |
Muteine von humanem lipocalin 2 (lcn2, hngal) mit affinität für ein bestimmtes zielmolekül
|
EP2582421A1
(de)
|
2010-06-21 |
2013-04-24 |
MannKind Corporation |
System und verfahren zur verabreichung von arzneimitteln in trockenpulverform
|
CN103533928A
(zh)
|
2011-03-10 |
2014-01-22 |
霍夫曼-拉罗奇有限公司 |
对具有改变的血管屏障功能的病症的治疗
|
ES2625858T3
(es)
|
2011-04-01 |
2017-07-20 |
Mannkind Corporation |
Paquete de tipo blíster para cartuchos farmacéuticos
|
US20140178398A1
(en)
|
2011-05-03 |
2014-06-26 |
Genentech, Inc |
Vascular disruption agents and uses thereof
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
CA2852536A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
WO2014012069A2
(en)
|
2012-07-12 |
2014-01-16 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
EP2687225A1
(de)
|
2012-07-19 |
2014-01-22 |
Alfact Innovation |
HIP/PAP-Protein und Derivate davon zur Verwendung bei der Behandlung von Krebs
|
EP2911690A1
(de)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalierbare influenza-impfstoffzusammensetzungen und verfahren
|
EP3587404B1
(de)
|
2013-03-15 |
2022-07-13 |
MannKind Corporation |
Mikrokristalline diketopiperazinzusammensetzungen, verfahren zur herstellung und deren verwendung
|
CA2891557A1
(en)
|
2013-03-26 |
2014-05-22 |
Pieris Ag |
Novel specific-binding polypeptides and uses thereof
|
BR112016000937A8
(pt)
|
2013-07-18 |
2021-06-22 |
Mannkind Corp |
formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco
|
EP3030294B1
(de)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflationsvorrichtung
|
AU2015205530B8
(en)
|
2014-01-13 |
2019-09-19 |
Pieris Pharmaceuticals Gmbh |
Multi-specific polypeptide useful for localized tumor immunomodulation
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
CA2888068A1
(en)
|
2014-04-15 |
2015-10-15 |
The Hospital For Sick Children |
Cationic antimicrobial peptides
|
BR112016027024A2
(pt)
|
2014-05-22 |
2017-10-31 |
Pieris Pharmaceuticals Gmbh |
polipeptídeos de ligação específica e seus usos
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
AU2016212087B2
(en)
|
2015-01-28 |
2019-11-07 |
Pieris Pharmaceuticals Gmbh |
Novel proteins specific for angiogenesis
|
CN114573680A
(zh)
|
2015-05-04 |
2022-06-03 |
皮里斯制药有限公司 |
Cd137特异性的蛋白
|
KR20170138574A
(ko)
|
2015-05-04 |
2017-12-15 |
피어이스 파마슈티컬즈 게엠베하 |
항암 융합 폴리펩타이드
|
CN108112253B
(zh)
|
2015-05-18 |
2022-09-23 |
皮里斯制药有限公司 |
抗癌融合多肽
|
WO2016184875A1
(en)
|
2015-05-18 |
2016-11-24 |
Pieris Pharmaceuticals Gmbh |
Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3)
|
EP3383921A4
(de)
|
2015-11-30 |
2019-04-17 |
Pieris Australia Pty Ltd. |
Neuartige antiangiogene fusionspolypeptide
|
TW201725212A
(zh)
|
2015-12-10 |
2017-07-16 |
第一三共股份有限公司 |
特異性於降鈣素基因相關胜肽的新穎蛋白
|
WO2023111664A1
(en)
*
|
2021-12-19 |
2023-06-22 |
Kamagtech Bio Pharma |
Device and method for use in treatment of pathogens
|